Highly active antiretroviral therapy used to treat concurrent hepatitis B and human immunodeficiency virus infections

Journal of Gastroenterology

Volumn 34, Issue 2, 1999, Pages 275-281

  Nagai, Kazuki ^a   Hosaka, Hiroo ^a   Kubo, Shuichi ^a   Nakamura, Noriko ^b   Shinohara, Masao ^c   Nonaka, Hiroko ^d  

^a Saiseikai Yokohama City Nanbu Hospital   (Japan)

^b Saiseikai Yokohama shi Nambu Hosp   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis B virus (HBV); Highly active antiretroviral therapy (HAART); Human immunodeficiency virus type 1 (HIV 1)

Indexed keywords

ANTIRETROVIRUS AGENT; DNA POLYMERASE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INDINAVIR; LAMIVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; AGGLUTINATION TEST; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TIME; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; GENE PRODUCTS, POL; HEPATITIS B ANTIBODIES; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; INDINAVIR; LAMIVUDINE; LIVER; MALE; ZIDOVUDINE;

EID: 0032958724     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050257     Document Type: Article

References (16)

1. McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JR, Forster GE, Thomas HC. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alfa-interferon. Hepatology 1987; 7:719-23.
2. Wong D, Yim C, Naylor D, et al. Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population. Gastroenterology 1995;108:165-71.
3. Benhamou Y, Katlaman C, Lunal F, Coutellier A, Dohin E, Hamm N, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996;125:705-12.
4. Ho DD. Can HIV be eradicated? In: Program and abstracts of the fourth conference on retroviruses and opportunistic infections. January 22-27, 1997; Washington, DC. Abstract SI.
5. Klaus BD, Grodesky MJ. HIV and HAAT in 1997. Highly active antiretroviral therapy (news). Nurse-Pract 1997;22:139-42.
6. Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, Macher AM. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:795-7.
7. Weissberg JI, Andres LL, Smith CL, Weick S. Nichols JE, Garcia G, et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 1984;101:613-6.
8. De Jongh FE, Janssen HLA, De Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterol 1992;103:1630-5.
9. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
10. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW. Major expansion of CD8+ T cells with predominant V-beta usage during the primary immune response to HIV. Nature 1994;370:463-7.
11. Hoofnagle JH, DiBisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-54.
12. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis Be antigen-positive chronic hepatitis B: A meta-analysis. Ann Intern Med 1993;119:312-23.
13. Wong DK, Yim C, Naylor CD, Chen E, Sherman M, Vas S, et al. Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population. Gastroenterol 1995;108:165-71.
14. Mai AL, Yim C, O'Rourke K, Heathcote EJ. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. J Clin Gastroenterol 1996;22:299-304.
15. Daudon M. Urinary stones in HIV-1-positive patients treated with indinavir. Lancet 1997;349:1294-5.
16. Anonymous. New drugs for HIV infection. The medical letter on drugs and therapeutics. 1996;38:35-7.